Innocoll
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Innocoll sits in the top decile of US sponsors by registered trial count (#772 of 15,742 sponsors by registered trial count).
Innocoll: 19 sponsored US clinical trials, none currently recruiting.
Innocoll sponsors 19 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 17 completed. 8 of these trials are in Phase 3-4 (later-stage) and 11 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hernioplasty, with 1 trials.
Top-decile sponsor footprint
Innocoll ranks in the top decile of sponsors by registered trial count (#772 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
17 of 19 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
19 total, page 1 of 1
Efficacy and Safety Study of Postsurgical Analgesia With INL-001 in Abdominoplasty
NCT04785625
An Open-label Safety and Pharmacokinetic Study of INL-001 in Adults Following Various Open Soft-Tissue Surgeries
NCT04785638
Pharmacokinetics, Relative Bioavailability and Safety of INL-001 Compared to Marcaine After Open Hernioplasty
NCT03234374
Phase 3 Study of Efficacy and Safety of the XaraColl® Bupivacaine Implant After Hernioplasty
NCT02525133
Phase 3 Study of Efficacy and Safety of the XaraColl® Bupivacaine Implant After Hernioplasty
NCT02523599
Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers
NCT02447172
Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers
NCT02427802
Pharmacokinetics, Relative Bioavailability and Safety of Xaracoll Implant
NCT02232178
Assess the Feasibility and Efficacy of the CollaRx® Bupivacaine Implant Laparoscopic Inguinal or Umbilical Herniorrhaphy
NCT01224145
Safety and Efficacy of CollaRx® Bupivacaine Implant in Men After Open Laparotomy Herniorrhaphy
NCT01220024
Efficacy and Safety of the CollaRx Bupivacaine Implant Compared to the ON-Q Painbuster Following Abdominal Hysterectomy
NCT00749749
Efficacy and Safety of A Collagen Bupivacaine Implant in Patients After Gastrointestinal Surgery
NCT00661466
The Safety and Efficacy of an Antibiotic Sponge in Diabetic Patients With Moderately Infected Foot Ulcers
NCT00659646
Prevention of Infection Using a Topical Gentamicin-Collagen Sponge in Diabetic Patients With An Uninfected Foot Ulcer
NCT00658957
Efficacy, Safety and Pharmacokinetic Profile of a Collagen Bupivacaine Implant in Men After Open Mesh Herniorrhaphy
NCT00626886
A Study of an Antibiotic Implant in General Surgical Subjects at Higher Risk for Surgical Wound Infection
NCT00600925
Efficacy and Safety of a Collagen Bupivacaine Implant in Women Following Abdominal Hysterectomy
NCT00624910
Safety and Efficacy of an Antibiotic Implant in Cardiac Surgical Subjects at Higher Risk for Sternal Wound Infection
NCT00600483
Safety and Efficacy of an Antibiotic Sponge in Diabetic Patients With a Mild Infection of a Foot Ulcer
NCT00593567
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 10 |
| Phase 3 | 8 |
Therapeutic Areas
How the Innocoll archive is shaped
19 indexed studies, none listed as recruiting (0% open); 17 completed (89%).
Phase mix: 8 late (III/IV) vs 11 early (I/II) (balanced across stages).
Top condition: Hernioplasty (1 trial), 6 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Innocoll: archived-pipeline peers nationwide
Peers matched on 19 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Innocoll sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 19 archived trials
- Almirall, S.A. · 19 trials · 5% recruiting
- Bastyr University · 19 trials · 11% recruiting
- Church & Dwight Company · 19 trials · 0% recruiting
- Cordis US · 19 trials · 5% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Innocoll page
19 registered trials is a research-attention snapshot, not an endorsement of Innocoll or any single study.
- None of Innocoll's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Hernioplasty is the condition Innocoll studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hernioplasty trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Innocoll pipeline card: 19 registered trials from official public datasets.Report a data error.